Search results
Showing 31 to 35 of 35 results for certolizumab pegol
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs (TA815)
Evidence-based recommendations on guselkumab (Tremfya) for active psoriatic arthritis after inadequate response to DMARDs in adults.
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease .
Evidence-based recommendations on apremilast (Otezla) for treating active psoriatic arthritis.
Evidence-based recommendations on ustekinumab (Stelara) for treating active psoriatic arthritis in adults.
New draft guidance from NICE means thousands of people suffering with severe rheumatoid arthritis will have more medicines to choose from.